CAS: 38284-47-8 - 4-{2-[2-(6,6-dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl}morpholine
Fórmula:C17H31NO2
InChI:InChI=1S/C17H31NO2/c1-17(2)15-4-3-14(16(17)13-15)5-9-19-10-6-18-7-11-20-12-8-18/h14-16H,3-13H2,1-2H3
Clave InChI:InChIKey=FPLHEALBGYMFJM-UHFFFAOYSA-N
SMILES:O1CCN(CC1)CCOCCC2CCC3CC2C3(C)C
- Sinónimos:
- 2-[2-(2-Morpholinoethoxy)ethyl]-6,6-dimethylnorpinane
- 6,6-Dimethyl-2-[2-(2-morpholinoethoxy)ethyl]norpinane
- Morpholine, 4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]Hept-2-Yl)Ethoxy]Ethyl]-
Pinaverium Impurity 6 HCl
Fórmula:
C17H31NO2·HCl
Forma y color:
White To Off-White Solid
Peso molecular:
281.44 36.46
Ref: 4Z-P-704
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Jueves 2 de Enero de 2025
Pinaverium Bromide Impurity 19 (Mixture of Diastereomers)
CAS:38284-47-8
Fórmula:
C17H31NO2
Peso molecular:
281.44
Ref: 4Z-P-7026
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
(1S,2S,5S)-4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholine
CAS:38284-47-8
Applications (1S,2S,5S)-4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholine, is used for the synthesis of Pinaverium Bromide (P465000), a drug used for …
Fórmula:
C17H31NO2
Forma y color:
Neat
Peso molecular:
281.43
Ref: TR-D464890
25mg | 330,00 € | ||
250mg | 2.209,00 € |
Entrega estimada en Estados Unidos, el Viernes 10 de Enero de 2025
(1S,2S,5S)-4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholine
CAS:38284-47-8
Please enquire for more information about (1S,2S,5S)-4-[2-[2-(6,6-Dimethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]morpholine including the price, delivery time and more detailed …
Fórmula:
C17H31NO2
Pureza:
Min. 95%
Peso molecular:
281.4 g/mol
Ref: 3D-NBA28447
2mg | 172,00 € | ||
5mg | 248,00 € | ||
10mg | 364,00 € | ||
25mg | 647,00 € | ||
50mg | 1.047,00 € |
Entrega estimada en Estados Unidos, el Martes 11 de Febrero de 2025